Syn2bio S.A. (WSE:S2B)

Market Cap	522.00M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	8.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,180
Open	60.00
Previous Close	60.28
Day's Range	57.10 - 60.00
52-Week Range	26.20 - 96.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 3, 2026

About Syn2bio

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It is also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2025
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: S2B

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 4, 2026

Data Sources Report a data error